42
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Subtypes in Monosymptomatic Nocturnal Enuresis II

Pages 8-11 | Published online: 09 Jul 2009

REFERENCES

  • Norgaard JP, van Gool JD, Hjälmas K, Djurhuus JC, Hellström A-L. Standardization and definitions in lower urinary tract dysfunction in children. Br J Urol 1998; 81: 1–16.
  • de Jonge GA Children with enuresis: an epidemiological and clinical study. Assen: van Gorcum & Co., 1969.
  • Houts AC, Berman JS, Abramson H. Effectiveness of psychological and pharmacological treatments for noc-turnal enuresis. J Consult Clin Psychol 1994; 62: 737–45.
  • von Gontard A, Lehmkuhl G. Drug therapy for enuresis. Z Kinder Jugendpsychiatr Psychother 1996; 24: 18–33.
  • Azrin NH, Sneed TJ, Foxx RM. Dry-bed training: rapid elimination of childhood enuresis. Behav Res Ther 1974; 12: 147–56.
  • Messer AP Zeer moeilijk eten en moelilijk beinvloed-baar bedplassen [dissertation]. Leiden University, 1979.
  • ten Doeschate IOM, van Gool JD, Messer AP. Long-term results of dry-bed training in 153 adolescents with nocturnal enuresis. Unpublished, 1998.
  • Norgaard JP, Pedersen EB, Djurhuss JC. Diurnal anti-diuretic-hormone levels in enuretics. J Urol 1985; 134: 1029–31.
  • Steffens J, Netzer M, Isenberg E, Alloussi S, Ziegler M. Vasopressin deficiency in primary nocturnal enuresis. Results of a controlled prospective study. Eur Urol 1993; 24: 366–70.
  • Kawauchi A, Watanabe H, Nakagawa S, Miyoshi K. Development of bladder capacity, nocturnal urinary volume and urinary behavior in nonenuretic and enuretic children. Nippon Hinyokika Gakkai Zasshi 1993; 84: 1811–20.
  • Hjälmas K, van Gool JD, von Gontard A, de Gennaro M, Lottmann H, Terho P. Nocturnal enuresis-European treatment strategy. Br Med J. in press.
  • Rushton HG, Belman AB, Skoog S, Zaontz MR, Sihelnik S. Predictors of response to desmopressin in children and adolescents with monosymptomatic noc-turnal enuresis. Scand J Urol Nephrol 1995; 173: 109–11.
  • Moffatt ME, Harlos S, Kirshen AJ, Burd L. Desmo-pressin acetate and nocturnal enuresis: how much do we know? [see comments]. Pediatrics 1993; 92: 420–5.
  • Bloom DA. The American experience with desmopres-sin. Clin Pediatr (Phila) 1993; Spec No.: 28–31.
  • Forsythe WI, Butler RJ. Fifty years of enuresis alarms. Arch Dis Child 1989; 64: 879–85.
  • Forsythe WI, Redmond A. Enuresis and spontaneous cure rate: study of 1129 enuretics. Arch Dis Child 1974; 49: 259–63.
  • Rappaport L. The treatment of nocturnal enuresis-where are we now? [see comments]. Pediatrics 1993; 92: 465–6.
  • van Londen A, van Londen-Barentsen MW, van Son MJ, Mulder GA. Arousal training for children suffering from nocturnal enuresis: a 2 1/2 year follow-up. Behav Res Ther 1993; 31: 613–5.
  • Cassone VM. Melatonin-time in a bottle. Oxford Rev Reprod Biol 1990; 12: 319–67.
  • Short RV. Melatonin-hormone of darkness. Br Med J 1993; 307: 952–3.
  • Cavallo A. The pineal gland in human beings: relevance to pediatrics. J Pediatr 1993; 123: 843–51.
  • Utiger RD. Melatonin-hormone of darkness. N Engl J Med 1992; 327: 1377–9.
  • Dahlitz M, Alvarez B, Vignau J, English J, Arendt J, Parkes JD. Delayed sleep phase syndrome response to melatonin. Lancet 1991; 337: 1121–4.
  • Haimov I, Laudon M, Zisapel N, Souroujon M, Nof D, Shlitner A. Sleep disorders and melatonin rhythms in elderly people. Br Med J 1994; 309: 167.
  • Jan JE, Espezel H, Appleton RE. The treatment of sleep disorders with melatonin [see comments]. Dev Med Child Neurol 1994; 36: 97–107.
  • Palm L, Blennow G, Wetterberg L. Long-term melato-nin treatment in blind children and young adults with circadian sleep-wake disturbances. Dev Med Child Neurol 1997; 39: 319–25.
  • Juszczak M, Debeljuk L, Stempniak B, Steger RW, Fadden C, Bartke A. Neurohypophyseal vasopressin in the Syrian hamster: response to short photoperiod, pinealectomy, melatonin treatment, or osmostic stimula-tion. Brain Res Bull 1997; 42: 221–5.
  • Kauppila A, Kivela P. Pakarinen A, Vakkuri O. Inverse seasonal relationship between melatonin and ovarian activity in humans in a region with a strong seasonal contrast in luminosity. J Clin Endocrinol Metab 1987; 65: 823–8.
  • Cavallo A. Plasma melatonin rhythm in normal puberty: interactions of age and pubertal stages. Neuroendocri-nology 1992; 55: 372–9.
  • Corio V. Volpi R, Caffarri GE. Effect of melatonin on hypoglycemia and metoclopramine-stimulated arginine vasopressin secretion in normal men. Neuropeptides 1997; 31: 323–6.
  • Stehle J, Reuss S, Riemann R, Seidel A, Vollrath L. The role of arginine vasopressin for pineal melatonin synthesis in the rat: involvement of vasopressinergic receptors. Neurosci Lett 1991; 123: 131–4.
  • Yasin SA, Costa A, Besser GM, Bucks D, Grossman A, Forsling ML. Melatonin and its analogs inhibit the basal and stimulated release of hypothalamic vasopressin and oxytocin in vitro. Endocrinology 1993; 132: 1329–36.
  • Jan JE, Me OD. Use of melatonin in the treatment of paediatric sleep disorders. J Pineal Res 1996; 21: 193–9.
  • Liu Y, Merrow M, Loros JJ, Dunlap JC. How temperature changes reset a circadian oscillator. Science 1998; 281: 825–9.
  • Oren DA, Terman M. Tweaking the human circadian clock with light. Science 1998; 279: 333–4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.